These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11171550)

  • 1. Gene targeting in hemostasis. Alpha2-antiplasmin.
    Lijnen HR
    Front Biosci; 2001 Feb; 6():D239-47. PubMed ID: 11171550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha2-antiplasmin gene deficiency in mice is associated with enhanced fibrinolytic potential without overt bleeding.
    Lijnen HR; Okada K; Matsuo O; Collen D; Dewerchin M
    Blood; 1999 Apr; 93(7):2274-81. PubMed ID: 10090937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced fibrinolytic potential in mice with combined homozygous deficiency of alpha2-antiplasmin and PAI-1.
    Dewerchin M; Collen D; Lijnen HR
    Thromb Haemost; 2001 Aug; 86(2):640-6. PubMed ID: 11522016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and targeting of the murine alpha2-antiplasmin gene.
    Okada K; Lijnen HR; Dewerchin M; Belayew A; Matsuo O; Collen D; Bernaerts R
    Thromb Haemost; 1997 Sep; 78(3):1104-10. PubMed ID: 9308761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation.
    Singh S; Houng A; Reed GL
    Circulation; 2017 Mar; 135(11):1011-1020. PubMed ID: 28028005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.
    Kluft C; Nieuwenhuis HK; Rijken DC; Groeneveld E; Wijngaards G; van Berkel W; Dooijewaard G; Sixma JJ
    J Clin Invest; 1987 Nov; 80(5):1391-400. PubMed ID: 2445779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmin generation plays different roles in the formation and removal of arterial and venous thrombus in mice.
    Matsuno H; Kozawa O; Okada K; Ueshima S; Matsuo O; Uematsu T
    Thromb Haemost; 2002 Jan; 87(1):98-104. PubMed ID: 11848464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha(2)-antiplasmin gene deficiency in mice does not affect neointima formation after vascular injury.
    Lijnen HR; Van Hoef B; Dewerchin M; Collen D
    Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1488-92. PubMed ID: 10845862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice.
    Nagai N; De Mol M; Lijnen HR; Carmeliet P; Collen D
    Circulation; 1999 May; 99(18):2440-4. PubMed ID: 10318667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous alpha2-antiplasmin does not enhance glomerular fibrin deposition or injury in glomerulonephritis.
    Kitching AR; Turner AL; O'Sullivan KM; Dewerchin M; Lijnen HR
    J Thromb Haemost; 2003 Sep; 1(9):1992-9. PubMed ID: 12941042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance.
    Carpenter SL; Mathew P
    Haemophilia; 2008 Nov; 14(6):1250-4. PubMed ID: 19141165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of fibrinolytic components play different roles in the formation and removal of arterial thrombus in mice.
    Matsuno H; Kozawa O; Okada K; Ueshima S; Matsuo O; Uematsu T
    J Cardiovasc Pharmacol; 2002 Feb; 39(2):278-86. PubMed ID: 11791014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the fibrinolytic and matrix metalloproteinase systems in arterial neointima formation after vascular injury.
    Lijnen HR
    Verh K Acad Geneeskd Belg; 2001; 63(6):605-22. PubMed ID: 11813512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha 2-antiplasmin deficiency in a Sudanese child: a case report.
    Mohammed BAB
    J Med Case Rep; 2021 May; 15(1):238. PubMed ID: 33957960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha2-antiplasmin on cardiovascular diseases.
    Matsuno H
    Curr Pharm Des; 2006; 12(7):841-7. PubMed ID: 16515500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-ray crystal structure of the fibrinolysis inhibitor alpha2-antiplasmin.
    Law RH; Sofian T; Kan WT; Horvath AJ; Hitchen CR; Langendorf CG; Buckle AM; Whisstock JC; Coughlin PB
    Blood; 2008 Feb; 111(4):2049-52. PubMed ID: 18063751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of the reactions between streptokinase, plasmin and alpha 2-antiplasmin.
    Cederholm-Williams SA; De Cock F; Lijnen HR; Collen D
    Eur J Biochem; 1979 Oct; 100(1):125-32. PubMed ID: 158524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reaction of human alpha2-antiplasmin and plasmin stopped-flow fluorescence kinetics.
    Christensen U; Bangert K; Thorsen S
    FEBS Lett; 1996 May; 387(1):58-62. PubMed ID: 8654567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of alpha2-antiplasmin promotes pulmonary heart failure via overrelease of VEGF after acute myocardial infarction.
    Matsuno H; Kozawa O; Yoshimi N; Akamatsu S; Hara A; Mori H; Okada K; Ueshima S; Matsuo O; Uematsu T
    Blood; 2002 Oct; 100(7):2487-93. PubMed ID: 12239160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.